PENLON LIMITEDActive
Key figures
PENLON LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Filed accounts2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Profit for the year | 1,625,998 | 765,877 | -1,757,829 |
| Cash at bank and in hand | 1,036,318 | 1,950,886 | 2,884,190 |
| Total assets | 14,987,014 | 14,938,489 | 14,219,670 |
| Total liabilities | 8,416,126 | — | 8,524,874 |
| Net assets / total equity | 6,570,888 | 7,336,765 | 12,265,340 |
| Average number of employees | 131 | 119 | 1 |
| Average pay (per year) | 33,702 | 46,796 | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company continued to be that of manufacturing medical instruments and supplies.
As described in the company's latest filed accounts.
Summary: PENLON LIMITED
Company
PENLON LIMITED is a private limited company registered with Companies House under company number 03228364. It was incorporated on 23 Jul 1996. Its status is active. The registered office is in Abingdon (OX14). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Loss for the year was £1,757,829. Net assets were £12,265,340, up 67.2% on the previous year. Cash at bank and in hand was £2,884,190. Total assets were £14,219,670 and total liabilities £8,524,874. The company had an average of 1 employee. Figures are available for 3 financial years (2023–2025).
Control and charges
One person with significant control is registered. 2 of 16 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 6 Aug 2027.